However, higher level of ALT, TG, FBG, and CK-18 M30 and CAP were observed in NASH compared with non-NASH group (P < 0.05), and the number of E antigen positive cases in NASH was fewer than that of non-NASH group (P < 0.05) (Table 1). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.